China Sends Experimental Ebola Drug To Africa For Clinical Trials

News outlets report that China has sent an experimental drug developed by its military to Africa for clinical trials.

Financial Times: China sends thousands of doses of anti-Ebola drug to Africa
“China has sent thousands of doses of an experimental anti-Ebola drug developed by the Chinese military to Africa. The company manufacturing the drug said it plans to start human clinical trials there soon. Sihuan Pharmaceutical, the private Chinese company that last week purchased the rights to commercialize jk-05 from a branch of the People’s Liberation Army (PLA), said it began manufacturing the drug after it was approved in August as a ‘special drug for military needs’…” (Waldmeir/Cookson, 10/15).

Reuters: China sends Ebola drug to Africa, eyes clinical trials
“A Chinese drugmaker with military ties has sent an experimental Ebola drug to Africa for use by Chinese aid workers and is planning clinical trials there to combat the disease, executives at the firm told Reuters on Thursday…” (Jourdan, 10/16).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.